Advan Six Inc. ASIX
We take great care to ensure that the data presented and summarized in this overview for AdvanSix Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ASIX
View all-
Black Rock Inc. New York, NY4.79MShares$152 Million0.0% of portfolio
-
Victory Capital Management Inc2.47MShares$78.4 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$61.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.57MShares$49.7 Million0.01% of portfolio
-
Alliancebernstein L.P. New York, NY1.33MShares$42.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.03MShares$32.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO639KShares$20.3 Million0.01% of portfolio
-
First Eagle Investment Management, LLC638KShares$20.3 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA598KShares$19 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL516KShares$16.4 Million0.03% of portfolio
Latest Institutional Activity in ASIX
Top Purchases
Top Sells
About ASIX
AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Insider Transactions at ASIX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2025
|
Erin N Kane Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.49%
|
$140,000
$28.5 P/Share
|
|
Dec 16
2024
|
Todd D. Karran Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,559
+1.91%
|
$46,770
$30.46 P/Share
|
|
Dec 16
2024
|
Patrick Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+1.52%
|
$12,900
$30.46 P/Share
|
|
Dec 02
2024
|
Erin N Kane Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.97%
|
$160,000
$32.29 P/Share
|
|
Nov 25
2024
|
Christopher Gramm Controller |
SELL
Open market or private sale
|
Direct |
1,951
-4.3%
|
$62,432
$32.0 P/Share
|
|
Nov 25
2024
|
Christopher Gramm Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,951
+4.12%
|
$27,314
$14.29 P/Share
|
|
Nov 18
2024
|
Donald P Newman Director |
BUY
Open market or private purchase
|
Direct |
5,030
+50.0%
|
$145,870
$29.64 P/Share
|
|
Nov 07
2024
|
Christopher Gramm Controller |
SELL
Open market or private sale
|
Direct |
505
-1.15%
|
$16,160
$32.0 P/Share
|
|
Nov 07
2024
|
Christopher Gramm Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
505
+1.14%
|
$7,070
$14.29 P/Share
|
|
Nov 06
2024
|
Christopher Gramm Controller |
SELL
Open market or private sale
|
Direct |
2,435
-5.31%
|
$77,920
$32.0 P/Share
|
|
Nov 06
2024
|
Christopher Gramm Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,435
+5.04%
|
$34,090
$14.29 P/Share
|
|
Nov 01
2024
|
Erin N Kane Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.48%
|
$150,000
$30.51 P/Share
|
|
Nov 01
2024
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
363
-1.08%
|
$11,253
$31.0 P/Share
|
|
Oct 04
2024
|
Christopher Gramm Controller |
SELL
Open market or private sale
|
Direct |
270
-0.62%
|
$8,640
$32.0 P/Share
|
|
Oct 04
2024
|
Christopher Gramm Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
270
+0.61%
|
$3,780
$14.29 P/Share
|
|
Oct 01
2024
|
Siddharth Manjeshwar SVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,437
+50.0%
|
-
|
|
Oct 01
2024
|
Erin N Kane Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.95%
|
$150,000
$30.28 P/Share
|
|
Oct 01
2024
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
350
-1.03%
|
$10,500
$30.18 P/Share
|
|
Sep 30
2024
|
Patrick Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
432
+1.55%
|
$12,960
$30.38 P/Share
|
|
Sep 30
2024
|
Todd D. Karran Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,564
+1.95%
|
$46,920
$30.38 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 349K shares |
|---|---|
| Exercise of conversion of derivative security | 10.4K shares |
| Open market or private purchase | 5.03K shares |
| Payment of exercise price or tax liability | 111K shares |
|---|---|
| Open market or private sale | 79.1K shares |